Plasma osteopontin as a marker for future organ damage in pediatric systemic lupus erythematosus
Main Authors: | Rullo Ornella J, Woo Jennifer MP, Hoftman Alice DC, Parsa Miriam F, Amarilyo Gil, McCurdy Deborah K, Tsao Betty P |
---|---|
Format: | Article |
Language: | English |
Published: |
BMC
2012-07-01
|
Series: | Pediatric Rheumatology Online Journal |
Online Access: | http://www.ped-rheum.com/content/10/S1/A123 |
Similar Items
-
Ethnic differences in pediatric SLE early disease severity: a comparison between Hispanic-Americans and European-Americans
by: Liu Peony, et al.
Published: (2012-07-01) -
Implementation of an electronic interface for the documentation of pediatric rheumatology medical records improves physician and patient utilization of time in clinic
by: Woo Jennifer MP, et al.
Published: (2012-07-01) -
Osteopontin Alleles Are Associated with Clinical Characteristics in Systemic Lupus Erythematosus
by: Tarak Trivedi, et al.
Published: (2011-01-01) -
Osteopontin and systemic lupus erythematosus association: a probable gene-gender interaction.
by: Shizhong Han, et al.
Published: (2008-03-01) -
The preliminary association study of osteopontin 707 C/T polymorphism with systemic lupus erythematosus in a Polish population
by: Beata Kaleta, et al.
Published: (2020-05-01)